Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,057 | -10,754 | N/A | N/A | N/A |
| Depreciation Amortization | 718 | 751 | N/A | N/A | N/A |
| Accounts receivable | -560 | -276 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -274 | 548 | N/A | N/A | N/A |
| Other Working Capital | -431 | 2,532 | N/A | N/A | N/A |
| Other Operating Activity | 6,924 | 1,859 | 0 | 0 | 0 |
| Operating Cash Flow | $-5,680 | $-5,341 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -176 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 250 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 12 | 0 | 0 | 0 |
| Investing Cash Flow | $-120 | $86 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,265 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 3,760 | N/A | N/A | N/A |
| Debt Repayment | -75 | -29 | N/A | N/A | N/A |
| Common Stock Issued | 22,290 | 1,249 | N/A | N/A | N/A |
| Other Financing Activity | 57 | -510 | 0 | 0 | 0 |
| Financing Cash Flow | $23,537 | $4,469 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 469 | 1,255 | N/A | N/A | N/A |
| End Cash Position | 18,206 | 469 | N/A | N/A | N/A |
| Net Cash Flow | $17,737 | $-785 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,680 | -5,341 | N/A | N/A | N/A |
| Capital Expenditure | -120 | -176 | N/A | N/A | N/A |
| Free Cash Flow | -5,800 | -5,516 | 0 | 0 | 0 |